Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000261247

Medchemexpress LLC Ard-2585 | 2757422-79-8 | 99.2% | C41H43ClN8O5 | 10MG
SDP

Supplier:  Medchemexpress LLC HY13943610MG

Encompass_Preferred

ARD-2585 is a potent, orally active proteolysis-targeting chimera (PROTAC) developed for preclinical research into androgen receptor-driven diseases such as advanced prostate cancer. It reduces androgen receptor protein levels in cellular assays and includes reported solubility and storage data suitable for laboratory handling; for research use only, not for human administration.

  • Potent, orally active degrader with demonstrated cellular efficacy.
  • Mechanism of action: PROTAC-mediated target degradation of the androgen receptor.
  • Characterized physicochemical properties, including molecular formula and molecular weight.
  • High solubility in DMSO and formulatable in aqueous vehicles for in vivo studies.
  • Stable under recommended laboratory storage conditions (sealed, protected from moisture and light).

Catalog No. 50-002-61247


May include imposed supplier surcharges.
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.